Psychedelics

Numinus Completes First Extraction of its Psilocybe Mushrooms

Numinus Completes First Extraction of its Psilocybe Mushrooms

editorDecember 17, 20206349 min read

VANCOUVER, BC, December 17, 2020 – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an…

Numinus Wellness Announces National Expansion with acquisition of Mindspace Wellbeing

Numinus Wellness Announces National Expansion with acquisition of Mindspace Wellbeing

editorDecember 15, 202056910 min read

VANCOUVER (December 15, 2020) – Numinus Wellness Inc. (“Numinus” or “Company”) (TSXV: NUMI),a company aimed at creating an…

MindMed Upsizes Previously Announced Bought Deal Public Offering

MindMed Upsizes Previously Announced Bought Deal Public Offering

editorDecember 15, 20207586 min read

NEW YORK, Dec. 15, 2020 /CNW/ – Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) (“MindMed”…

Health Canada Announces Intent to Revise Special Access Program

Health Canada Announces Intent to Revise Special Access Program

editorDecember 14, 20206762 min read

Health Canada announced on December 11th 2020 that it has intention to revise the Special…

MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

editorDecember 14, 20205556 min read

NEW YORK, Dec. 14, 2020 /PRNewswire/ — MindMed (NEO: MMED,OTCQB: MMEDF, DE: MMQ), a leading psychedelic medicine biotech company…

Load More